Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease

Clinical Science

Volumn 130, Issue 15, 2016, Pages 1307-1326

  Chow, Bryna S M ^a   Allen, Terri J ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

AT2 receptor; AT2R agonism; Cardiovascular; Compound 21; Kidney

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CARDIOVASCULAR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; KIDNEY DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; METABOLISM;

ANGIOTENSIN II; ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; KIDNEY; KIDNEY DISEASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 85003948299     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160243     Document Type: Article

References (237)

1. Vukelic, S. and Griendling, K.K. (2014) Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift. Circ. Res. 114, 754-757.
2. Cooper, M.E. (2004) The role of the renin-angiotensinaldosterone system in diabetes and its vascular complications. Am. J. Hypertens. 17(11 Pt 2), 16S-20S.
3. Kobori, H., Nangaku, M., Navar, L.G. and Nishiyama, A. (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59, 251-287.
4. Uehara, Y., Miura, S., Yahiro, E. and Saku, K. (2013) Non-ACE pathway-induced angiotensin II production. Curr. Pharm. Des. 19, 3054-3059.
5. Becari, C., Oliveira, E.B. and Salgado, M.C. (2011) Alternative pathways for angiotensin II generation in the cardiovascular system. Braz. J. Med. Biol. Res. 44, 914-919.
6. Jones, E.S., Vinh, A., McCarthy, C.A., Gaspari, T.A. and Widdop, R.E. (2008) AT2 receptors: functional relevance in cardiovascular disease. Pharmacol. Ther. 120, 292-316.
7. Chai, S.Y., Fernando, R., Peck, G., Ye, S.Y., Mendelsohn, F.A., Jenkins, T.A. and Albiston, A.L. (2004) The angiotensin IV/AT4 receptor. Cell. Mol. Life Sci. 61, 2728-2737.
8. Santos, R.A., Ferreira, A.J., Verano-Braga, T. and Bader, M. (2013) Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216, R1-R17.
9. Santos, R.A., Ferreira, A.J. and Simoes, E.S.A.C. (2008) Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp. Physiol. 93, 519-527.
10. Santos, R.A., Simoes e Silva, A.C., Maric, C., Silva, D.M., Machado, R.P., de Buhr, I., Heringer-Walther, S., Pinheiro, S.V., Lopes, M.T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263.
11. Albiston, A.L., McDowall, S.G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F.A., Simpson, R.J., Connolly, L.M. and Chai, S.Y. (2001) Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276, 48623-48626.
12. Vinh, A., Widdop, R.E., Chai, S.Y. and Gaspari, T.A. (2008) Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma. Atherosclerosis 200, 37-44.
13. Vinh, A., Widdop, R.E., Drummond, G.R. and Gaspari, T.A. (2008) Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Cardiovasc. Res. 77, 178-187.
14. Walters, P.E., Gaspari, T.A. and Widdop, R.E. (2005) Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 45, 960-966.
15. De Souza, A.M., Lopes, A.G., Pizzino, C.P., Fossari, R.N., Miguel, N.C., Cardozo, F.P., Abi-Abib, R., Fernandes, M.S., Santos, D.P. and Caruso-Neves, C. (2004) Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+-ATPase activity through AT2 receptor. Regul. Pept. 120, 167-175.
16. Tesanovic, S., Vinh, A., Gaspari, T.A., Casley, D. and Widdop, R.E. (2010) Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30, 1606-1613.
17. Padia, S.H., Kemp, B.A., Howell, N.L., Fournie-Zaluski, M.C., Roques, B.P. and Carey, R.M. (2008) Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension 51, 460-465.
18. Padia, S.H., Howell, N.L., Siragy, H.M. and Carey, R.M. (2006) Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 47, 537-544.
19. van Esch, J.H., Oosterveer, C.R., Batenburg, W.W., van Veghel, R. and Jan Danser, A.H. (2008) Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor? Eur. J. Pharmacol. 588, 286-293
20. Bosnyak, S., Jones, E.S., Christopoulos, A., Aguilar, M.I., Thomas, W.G. and Widdop, R.E. (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin. Sci. (Lond). 121, 297-303.
21. Zuo, Y.M., Wang, Y. and Liu, J.P. (2010) Recent advances and findings of angiotensin type 2 receptor: a review. Chin. Med. J. (Engl). 123, 3462-3466.
22. Ruster, C. and Wolf, G. (2011) Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J. Am. Soc. Nephrol. 22, 1189-1199.
23. Mehta, P.K. and Griendling, K.K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82-C97.
24. de Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W. and Unger, T. (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415-472.
25. Matsubara, H. (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 83, 1182-1191.
26. Dasgupta, C. and Zhang, L. (2011) Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov. Today 16, 22-34.
27. Magnani, F., Pappas, C.G., Crook, T., Magafa, V., Cordopatis, P., Ishiguro, S., Ohta, N., Selent, J., Bosnyak, S., Jones, E.S. et al. (2014) Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. ACS Chem. Biol. 9, 1420-1425.
28. Levy, B.I. (2005) How to explain the differences between renin angiotensin system modulators. Am. J. Hypertens. 18 (9 Pt 2), 134S-141S.
29. Li, Y., Li, X.H. and Yuan, H. (2012) Angiotensin II type-2 receptor-specific effects on the cardiovascular system. Cardiovasc. Diagn. Ther. 2, 56-62.
30. Steckelings, U.M., Kaschina, E. and Unger, T. (2005) The AT2 receptor-a matter of love and hate. Peptides 26, 1401-1409.
31. Johren, O., Dendorfer, A. and Dominiak, P. (2004) Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc. Res. 62, 460-467.
32. Yu, L., Shao, C. and Gao, L. (2014) Developmental expression patterns for angiotensin receptors in mouse skin and brain. J. Renin Angiotensin Aldosterone Syst. 15, 139-149.
33. Sayeski, P.P., Ali, M.S., Semeniuk, D.J., Doan, T.N. and Bernstein, K.E. (1998) Angiotensin II signal transduction pathways. Regulatory peptides 78, 19-29.
34. Schmitz, U. and Berk, B.C. (1997) Angiotensin II signal transduction: stimulation of multiple mitogen-activated protein kinase pathways. Trends Endocrinol. Metab. 8, 261-266.
35. Chow, B.S., Kocan, M., Bosnyak, S., Sarwar, M., Wigg, B., Jones, E.S., Widdop, R.E., Summers, R.J., Bathgate, R.A., Hewitson, T.D. and Samuel, C.S. (2014) Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. Kidney Int. 86, 75-85.
36. Koulis, C., Chow, B.S., McKelvey, M., Steckelings, U.M., Unger, T., Thallas-Bonke, V., Thomas, M.C., Cooper, M.E., Jandeleit-Dahm, K.A. and Allen, T.J. (2015) AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy. Hypertension 65, 1073-1081.
37. Ager, E.I., Chong, W.W., Wen, S.W. and Christophi, C. (2010) Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int. 10, 19.
38. Pessoa, B.S., Slump, D.E., Ibrahimi, K., Grefhorst, A., van Veghel, R., Garrelds, I.M., Roks, A.J., Kushner, S.A., Danser, A.H. and van Esch, J.H. (2015) Angiotensin II type 2 receptorand acetylcholine-mediated relaxation: essential contribution of female sex hormones and chromosomes. Hypertension 66, 396-402.
39. Ferguson, S.S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 1-24.
40. Claing, A., Laporte, S.A., Caron, M.G. and Lefkowitz, R.J. (2002) Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 66, 61-79.
41. Sibley, D.R., Benovic, J.L., Caron, M.G. and Lefkowitz, R.J. (1987) Regulation of transmembrane signaling by receptor phosphorylation. Cell 48, 913-922.
42. Tobin, A.B. (2008) G-protein-coupled receptor phosphorylation: where, when and by whom. Br. J. Pharmacol. 153(Suppl 1), S167-S176.
43. Porrello, E.R., Pfleger, K.D., Seeber, R.M., Qian, H., Oro, C., Abogadie, F., Delbridge, L.M. and Thomas, W.G. (2011) Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles. Cell. Signal. 23, 1767-1776.
44. Turu, G., Szidonya, L., Gaborik, Z., Buday, L., Spat, A., Clark, A.J. and Hunyady, L. (2006) Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors. FEBS Lett. 580, 41-45.
45. Miura, S., Karnik, S.S. and Saku, K. (2005) Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J. Biol. Chem. 280, 18237-18244.
46. Mogi, M., Iwai, M. and Horiuchi, M. (2007) Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler. Thromb. Vasc. Biol. 27, 2532-2539.
47. Zhang, X., Wang, G., Dupre, D.J., Feng, Y., Robitaille, M., Lazartigues, E., Feng, Y.H., Hébert, T.E. and Wu, G. (2009) Rab1 GTPase and dimerization in the cell surface expression of angiotensin II type 2 receptor. J. Pharmacol. Exp. Ther. 330, 109-117.
48. Padia, S.H., Kemp, B.A., Howell, N.L., Gildea, J.J., Keller, S.R. and Carey, R.M. (2009) Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension 53, 338-343.
49. Gildea, J.J., Wang, X., Shah, N., Tran, H., Spinosa, M., Van Sciver, R., Sasaki, M., Yatabe, J., Carey, R.M., Jose, P.A. and Felder, R.A. (2012) Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 60, 396-403.
50. Kemp, B.A., Howell, N.L., Gildea, J.J., Keller, S.R., Padia, S.H. and Carey, R.M. (2014) AT2 receptor activation induces natriuresis and lowers blood pressure. Circ. Res. 115, 388-399.
51. Jang, J.H., Chun, J.N., Godo, S., Wu, G., Shimokawa, H., Jin, C.Z., Jeon, J.H., Kim, S.J., Jin, Z.H. and Zhang, Y.H. (2015) ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes. Basic Res. Cardiol. 110, 21.
52. Widdop, R.E., Jones, E.S., Hannan, R.E. and Gaspari, T.A. (2003) Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol. 140, 809-824.
53. AbdAlla, S., Lother, H., Abdel-tawab, A.M. and Quitterer, U. (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem. 276, 39721-39726.
54. Yang, J., Chen, C., Ren, H., Han, Y., He, D., Zhou, L., Hopfer, U., Jose, P.A. and Zeng, C. (2012) Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J. Hypertens. 30, 1176-1184.
55. Villela, D.C., Munter, L.-M., Multhaup, G., Mayer, M., Benz, V., Namsolleck, P. et al. (2012) 398 Evidence of a direct Mas-AT2 receptor dimerization. J. Hypertens. 30, e117.
56. Mecca, A.P., Regenhardt, R.W., O'Connor, T.E., Joseph, J.P., Raizada, M.K., Katovich, M.J. and Sumners, C. (2011) Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084-1096.
57. Jiang, T., Gao, L., Zhu, X.C., Yu, J.T., Shi, J.Q., Tan, M.S., Lu, J., Tan, L. and Zhang, Y.D. (2013) Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats. Pharmacol. Res. 71, 61-68.
58. Roks, A.J., Nijholt, J., van Buiten, A., van Gilst, W.H., de Zeeuw, D. and Henning, R.H. (2004) Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II. J. Hypertens. 22, 2355-2361.
59. Durand, M.J., Raffai, G., Weinberg, B.D. and Lombard, J.H. (2010) Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 299, H1024-H1033.
60. Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C.F., Heringer-Walther, S., Sexton, P.M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P. et al. (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806-1813.
61. Ferreira, A.J., Bader, M. and Santos, R.A. (2012) Therapeutic targeting of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review. Expert Opin. Ther. Pat. 22, 567-574.
62. Li, J., Zhao, X., Li, X., Lerea, K.M. and Olson, S.C. (2007) Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G alpha i3/Ras/Raf/MAPK pathway. Am. J. Physiol. Cell Physiol. 292, C2185-C2196.
63. Lemarie, C.A. and Schiffrin, E.L. (2010) The angiotensin II type 2 receptor in cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 11, 19-31.
64. Haithcock, D., Jiao, H., Cui, X.L., Hopfer, U. and Douglas, J.G. (1999) Renal proximal tubular AT2 receptor: signaling and transport. J. Am. Soc. Nephrol. 10 Suppl 11, S69-S74.
65. Siragy, H.M. and Carey, R.M. (1997) The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100, 264-269.
66. Siragy, H.M., Inagami, T., Ichiki, T. and Carey, R.M. (1999) Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 6506-6510.
67. Rodebaugh, J., Sekulic, M., Davies, W., Montgomery, S., Khraibi, A., Solhaug, M.J. and Ratliff, B.B. (2012) Neuronal nitric oxide synthase, nNOS, regulates renal hemodynamics in the postnatal developing piglet. Pediatr. Res. 71, 144-149.
68. Abadir, P.M., Periasamy, A., Carey, R.M. and Siragy, H.M. (2006) Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 48, 316-322.
69. Carey, R.M. (2013) The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure. Hypertension 61, 673-680.
70. Herrera, M. and Garvin, J.L. (2010) Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation. J. Biol. Chem. 285, 14932-14940.
71. Bergaya, S., Hilgers, R.H., Meneton, P., Dong, Y., Bloch-Faure, M., Inagami, T., Alhenc-Gelas, F., Lévy, B.I. and Boulanger, C.M. (2004) Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ. Res. 94, 1623-1629,2004.
72. Abadir, P.M., Carey, R.M. and Siragy, H.M. (2003) Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 42, 600-604.
73. Sabuhi, R., Asghar, M. and Hussain, T. (2010) Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats. Am. J. Physiol. Renal Physiol. 299, F815-F820.
74. Alexander, L.D., Ding, Y., Alagarsamy, S., Cui, X.L. and Douglas, J.G. (2006) Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. Kidney Int. 69, 1823-1832.
75. Jing, T., Wang, H., Srivenugopal, K.S., He, G., Liu, J., Miao, L. and He, Y. (2009) Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase expression and vascular remodeling. Int. J. Mol. Med. 24, 103-110.
76. Lauer, D., Slavic, S., Sommerfeld, M., Thone-Reineke, C., Sharkovska, Y., Hallberg, A., Dahlöf, B., Kintscher, U., Unger, T., Steckelings, U.M. and Kaschina, E. (2014) Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor beta1 in the rat heart. Hypertension 63, e60-e67.
77. Kljajic, S.T., Widdop, R.E., Vinh, A., Welungoda, I., Bosnyak, S., Jones, E.S. and Gaspari, T.A. (2013) Direct AT(2) receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice. Int. J. Cardiol. 169, 281-287.
78. Zhang, C., Hein, T.W., Wang, W. and Kuo, L. (2003) Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res 92, 322-329.
79. Hunyady, L. and Catt, K.J. (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20, 953-970.
80. Faria-Costa, G., Leite-Moreira, A. and Henriques-Coelho, T. (2014) Cardiovascular effects of the angiotensin type 2 receptor. Rev. Port. Cardiol. 33, 439-449.
81. Carey, R.M. and Padia, S.H. (2013) Role of angiotensin AT(2) receptors in natriuresis: intrarenal mechanisms and therapeutic potential. Clin. Exp. Pharmacol. Physiol. 40, 527-534.
82. Nouet, S., Amzallag, N., Li, J.M., Louis, S., Seitz, I., Cui, T.X., Alleaume, A.M., Di Benedetto, M., Boden, C. and Masson, M. (2004) Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem. 279, 28989-28997.
83. Wruck, C.J., Funke-Kaiser, H., Pufe, T., Kusserow, H., Menk, M., Schefe, J.H., Kruse, M.L., Stoll, M. and Unger, T. (2005) Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arteriosclerosis. Thromb. Vasc. Biol. 25, 57-64
84. Bundschu, K. and Schuh, K. (2014) Cardiovascular ATIP (angiotensin receptor type 2 interacting protein) expression in mouse development. Dev. Dyn. 243, 699-711.
85. Wang, N., Frank, G.D., Ding, R., Tan, Z., Rachakonda, A., Pandolfi, P.P., Senbonmatsu, T., Landon, E.J. and Inagami, T. (2012) Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. PLoS One 7, e35632.
86. Senbonmatsu, T., Saito, T., Landon, E.J., Watanabe, O., Price, E. Jr., Roberts, R.L., Imboden, H., Fitzgerald, T.G., Gaffney, F.A. and Inagami, T. (2003) A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 22, 6471-6482.
87. Funke-Kaiser, H., Reinemund, J., Steckelings, U.M. and Unger, T. (2010) Adapter proteins and promoter regulation of the angiotensin AT2 receptor-implications for cardiac pathophysiology. J. Renin Angiotensin Aldosterone Syst. 11, 7-17.
88. Namsolleck, P., Recarti, C., Foulquier, S., Steckelings, U.M. and Unger, T. (2014) AT(2) receptor and tissue injury: therapeutic implications. Curr. Hypertens. Rep. 16, 416.
89. Sampson, A.K., Moritz, K.M. and Denton, K.M. (2012) Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats. Gend. Med. 9, 21-32.
90. Brown, R.D., Hilliard, L.M., Mirabito, K.M., Wirth, L.C., Moritz, K.M., Evans, R.G. and Denton, K.M. (2014) Reduced sensitivity of the renal vasculature to angiotensin II in young rats: the role of the angiotensin type 2 receptor. Pediatr. Res. 76, 448-452.
91. Yosypiv, I.V. (2008) A new role for the renin-angiotensin system in the development of the ureteric bud and renal collecting system. Keio J. Med. 57, 184-189.
92. Yamada, H., Akishita, M., Ito, M., Tamura, K., Daviet, L., Lehtonen, J.Y., Dzau, V.J. and Horiuchi, M. (1999) AT2 receptor and vascular smooth muscle cell differentiation in vascular development. Hypertension 33, 1414-1419.
93. Oshima, K., Miyazaki, Y., Brock, 3rd, J.W., Adams, M.C., Ichikawa, I. and Pope, 4th, J.C. (2001) Angiotensin type II receptor expression and ureteral budding. J Urol. 166, 1848-1852.
94. Iosipiv, I.V. (2002) Cellular expression of the angiotensin type 2 receptor (AT2) during murine organogenesis. J. Invest. Med. 50, 134A
95. Song, R., Spera, M., Garrett, C., El-Dahr, S.S. and Yosypiv, I.V. (2010) Angiotensin II AT2 receptor regulates ureteric bud morphogenesis. Am. J. Physiol. Renal Physiol. 298, F807-F817.
96. Ratliff, B., Rodebaugh, J., Sekulic, M., Dong, K.W. and Solhaug, M. (2009) Nitric oxide synthase and renin-angiotensin gene expression and NOS function in the postnatal renal resistance vasculature. Pediatr. Nephrol. 24, 355-365.
97. Fong, D., Denton, K.M., Moritz, K.M., Evans, R. and Singh, R.R. (2014) Compensatory responses to nephron deficiency: adaptive or maladaptive? Nephrology (Carlton) 19, 119-128.
98. Toth-Heyn, P. and Cataldi, L. (2012) Vasoactive compounds in the neonatal period. Curr. Med. Chem. 19, 4633-4639.
99. Lo, M., Liu, K.L., Lantelme, P. and Sassard, J. (1995) Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J. Clin. Invest. 95, 1394-1397.
100. Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K. et al. (1999) Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104, 925-935.
101. Rukavina Mikusic, N.L., Kravetz, M.C., Kouyoumdzian, N.M., Della Penna, S.L., Roson, M.I., Fernandez, B.E. and Choi, M.R. (2014) Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system. J. Signal Transduct. 2014, 731350.
102. Ozono, R., Wang, Z.Q., Moore, A.F., Inagami, T., Siragy, H.M. and Carey, R.M. (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30, 1238-1246.
103. Miyata, N., Park, F., Li, X.F. and Cowley, Jr, A.W. (1999) Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am. J. Physiol. 277 (3 Pt 2), F437-F446.
104. Padia, S.H., Kemp, B.A., Howell, N.L., Siragy, H.M., Fournie-Zaluski, M.C., Roques, B.P. and Carey, R.M. (2007) Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats. Hypertension 49, 625-630.
105. Hakam, A.C., Siddiqui, A.H. and Hussain, T. (2006) Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats. Am. J. Physiol. Renal Physiol. 290, F503-F508.
106. Hakam, A.C. and Hussain, T. (2005) Renal angiotensin II type-2 receptors are upregulated and mediate the candesartaninduced natriuresis/diuresis in obese Zucker rats. Hypertension 45, 270-275.
107. Gross, V., Schunck, W.H., Honeck, H., Milia, A.F., Kargel, E., Walther, T., Bader, M., Inagami, T., Schneider, W. and Luft, F.C. (2000) Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int. 57, 191-202.
108. Ali, Q. and Hussain, T. (2012) AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. Hypertens. Res. 35, 654-660.
109. Kemp, B.A., Bell, J.F., Rottkamp, D.M., Howell, N.L., Shao, W., Navar, L.G., Padia, S.H. and Carey, R.M. (2012) Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 60, 387-395.
110. Yatabe, J., Yoneda, M., Yatabe, M.S., Watanabe, T., Felder, R.A., Jose, P.A. and Sanada, H. (2011) Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology 152, 1582 -1588.
111. Hong, N.J. and Garvin, J.L. (2012) Angiotensin II type 2 receptor-mediated inhibition of NaCl absorption is blunted in thick ascending limbs from Dahl salt-sensitive rats. Hypertension 60, 765-769.
112. Savoia, C., Touyz, R.M., Volpe, M. and Schiffrin, E.L. (2007) Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 49, 341-346.
113. Lee, S.Y., Kim, S.I. and Choi, M.E. (2015) Therapeutic targets for treating fibrotic kidney diseases. Transl. Res. 165, 512-530.
114. Duffield, J.S. (2014) Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Invest. 124, 2299-2306.
115. Benndorf, R.A., Krebs, C., Hirsch-Hoffmann, B., Schwedhelm, E., Cieslar, G., Schmidt-Haupt, R., Steinmetz, O.M., Meyer-Schwesinger, C., Thaiss, F., Haddad, M. et al. (2009) Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int. 75, 1039-1049.
116. Ma, J., Nishimura, H., Fogo, A., Kon, V., Inagami, T. and Ichikawa, I. (1998) Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 53, 937-944.
117. Morrissey, J.J. and Klahr, S. (1999) Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am. J. Physiol.276 (1 Pt 2), F39-F45.
118. Hashimoto, N., Maeshima, Y., Satoh, M., Odawara, M., Sugiyama, H., Kashihara, N., Matsubara, H., Yamasaki, Y. and Makino, H. (2004) Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am. J. Physiol. Renal Physiol. 286, F516-F525.
119. Siragy, H.M., Inagami, T. and Carey, R.M. (2007) NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1461-R1467.
120. Chang, S.Y., Chen, Y.W., Chenier, I., Tran Sle, M. and Zhang, S.L. (2011) Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp. Diabetes Res. 2011,521076.
121. Sourris, K.C., Morley, A.L., Koitka, A., Samuel, P., Coughlan, M.T., Penfold, S.A., Thomas, M.C., Biehaus, A., Nawroth, P.P., Yamamoto, H. et al. (2010) Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia. 53, 2442-2451.
122. Matavelli, L.C., Zatz, R. and Siragy, H.M. (2015) A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes. J. Cardiovasc. Pharmacol. 65, 371-376.
123. Wenzel, U.O., Krebs, C. and Benndorf, R. (2010) The angiotensin II type 2 receptor in renal disease. J. Renin Angiotensin Aldosterone Syst. 11, 37-41.
124. Steckelings, U.M., Rompe, F., Kaschina, E., Namsolleck, P., Grzesiak, A., Funke-Kaiser, H., Bader, M. and Unger, T. (2010) The past, present and future of angiotensin II type 2 receptor stimulation. J. Renin Angiotensin Aldosterone Syst. 11, 67-73.
125. Cao, Z., Bonnet, F., Candido, R., Nesteroff, S.P., Burns, W.C., Kawachi, H., Shimizu, F., Carey, R.M., De Gasparo, M. and Cooper, M.E. (2002) Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J. Am. Soc. Nephrol. 13, 1773-1787.
126. Esteban, V., Lorenzo, O., Ruperez, M., Suzuki, Y., Mezzano, S., Blanco, J., Kretzler, M., Sugaya, T., Egido, J. and Ruiz-Ortega, M. (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 1514-1529.
127. Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A.K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlén, A. et al. (2004) Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J. Med. Chem. 47, 5995-6008.
128. Castoldi, G., di Gioia, C.R., Bombardi, C., Maestroni, S., Carletti, R., Steckelings, U.M., Dahlöf, B., Unger, T., Zerbini, G. and Stella, A. (2014) Prevention of diabetic nephropathy by compound 21, selective agonist of the angiotensin type 2 receptors, in Zucker diabetic fatty rats. Am. J. Physiol. Renal Physiol. 307, F1123-F1131.
129. Duke, L.M., Evans, R.G. and Widdop, R.E. (2005) AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 288, H2289-H2297.
130. Probstfield, J.L. and O'Brien, K.D. (2010) Progression of cardiovascular damage: the role of renin-angiotensin system blockade. Am. J. Cardiol. 105 (1 Suppl), 10A-20A.
131. Naito, T., Ma, L.J., Yang, H., Zuo, Y., Tang, Y., Han, J.Y., Kon, V. and Fogo, A.B. (2010) Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am. J. Physiol. Renal Physiol. 298, F683-F691.
132. Guo, S., Kowalewska, J., Wietecha, T.A., Iyoda, M., Wang, L., Yi, K., Spencer, M., Banas, M., Alexandrescu, S., Hudkins, K.L. and Alpers, C.E. (2008) Renin- angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J. Am. Soc. Nephrol. 19, 1168-1176.
133. Artham, S., Fouda, A.Y., El-Remessy, A.B. and Fagan, S.C. (2015) Vascular protective effects of angiotensin receptor blockers: beyond blood pressure. Receptors Clin. Investig. 2, e774.
134. Siragy, H.M., de Gasparo, M., El-Kersh, M. and Carey, R.M. (2001) Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP. Hypertension 38, 183-186.
135. Ha, K.S., Yoo, K.H., Yim, H.E., Jang, G.Y., Bae, I.S., Hong, Y.S. and Lee, J.W. (2011) Cellular and RAS changes in the hearts of young obese rats. Pediatr. Cardiol. 32, 659-666.
136. Banos, M., Arellano-Mendoza, M.G., Vargas-Robles, H., Avila-Casado, M.C., Soto, V., Romo, E., Rios, A., Hernandez-Zavala, A., de la Peña-Diaz, A. and Escalante, B. (2011) Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with coronary occlusive disease. Exp. Mol. Pathol. 91, 478-483.
137. Batenburg, W.W., Garrelds, I.M., Bernasconi, C.C., Juillerat-Jeanneret, L., van Kats, J.P., Saxena, P.R. and Danser, A.H. (2004) Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 109, 2296-2301.
138. Gauthier, K.M., Zhang, D.X., Edwards, E.M., Holmes, B. and Campbell, W.B. (2005) Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocrinology 146, 3319-3324.
139. Yayama, K., Horii, M., Hiyoshi, H., Takano, M., Okamoto, H., Kagota, S. and Kunitomo, M. (2004) Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J. Pharmacol. Exp. Ther. 308, 736-743.
140. Chai, W., Wang, W., Liu, J., Barrett, E.J., Carey, R.M., Cao, W. and Liu, Z. (2010) Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55, 523-530.
141. Ichiki, T., Labosky, P.A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B.L. and Inagami, T. (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377, 748-750.
142. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J. and Kobilka, B.K. (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377, 744-747.
143. Gross, V., Milia, A.F., Plehm, R., Inagami, T. and Luft, F.C. (2000) Long-term blood pressure telemetry in AT2 receptor-disrupted mice. J. Hypertens. 18, 955-961.
144. Vazquez, E., Coronel, I., Bautista, R., Romo, E., Villalon, C.M., Avila-Casado, M.C., Soto, V. and Escalante, B. (2005) Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. Am. J. Physiol. Renal Physiol. 288, F207-F213.
145. Kurisu, S., Ozono, R., Oshima, T., Kambe, M., Ishida, T., Sugino, H., Matsuura, H., Chayama, K., Teranishi, Y., Iba, O. et al. (2003) Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 41, 99-107.
146. Falcon, B.L., Stewart, J.M., Bourassa, E., Katovich, M.J., Walter, G., Speth, R.C., Sumners, C. and Raizada, M.K. (2004) Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol. Genomics 19, 255-261.
147. Yan, X., Schuldt, A.J., Price, R.L., Amende, I., Liu, F.F., Okoshi, K., Ho, K.K., Pope, A.J., Borg, T.K., Lorell, B.H. and Morgan, J.P. (2008) Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 294, H1274-H1281.
148. Masaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Mauyama, K., Horiuchi, M. et al. (1998) Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest. 101, 527-535.
149. Cosentino, F., Savoia, C., De Paolis, P., Francia, P., Russo, A., Maffei, A., Venturelli, V., Schiavoni, M., Lembo, G. and Volpe, M. (2005) Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am. J. Hypertens. 18(4 Pt 1), 493-499.
150. Katada, J. and Majima, M. (2002) AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br. J. Pharmacol. 136, 484-491.
151. Moltzer, E., Verkuil, A.V., van Veghel, R., Danser, A.H. and van Esch, J.H. (2010) Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 55, 516-522.
152. You, D., Loufrani, L., Baron, C., Levy, B.I., Widdop, R.E. and Henrion, D. (2005) High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 111, 1006-1011.
153. Tschope, C., Westermann, D., Dhayat, N., Dhayat, S., Altmann, C., Steendijk, P., Schultheiss, H.P. and Walther, T. (2005) Angiotensin AT2 receptor deficiency after myocardial infarction: its effects on cardiac function and fibrosis depend on the stimulus. Cell Biochem. Biophys. 43, 45-52.
154. Oishi, Y., Ozono, R., Yano, Y., Teranishi, Y., Akishita, M., Horiuchi, M., Oshima, T. and Kambe, M. (2003) Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension 41(3 Pt 2), 814-818.
155. Koitka, A., Cao, Z., Koh, P., Watson, A.M., Sourris, K.C., Loufrani, L., Soro-Paavonen, A., Walther, T., Woollard, K.J., Jandeleit-Dahm, K.A. et al. (2010) Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. Diabetologia 53, 584-592.
156. Brede, M., Roell, W., Ritter, O., Wiesmann, F., Jahns, R., Haase, A., Fleischmann, B.K. and Hein, L. (2003) Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension 42, 1177-1182.
157. Adachi, Y., Saito, Y., Kishimoto, I., Harada, M., Kuwahara, K., Takahashi, N., Kawakami, R., Nakanishi, M., Nakagawa, Y., Tanimoto, K. et al. (2003) Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 107, 2406-2408.
158. Qi, Y., Li, H., Shenoy, V., Li, Q., Wong, F., Zhang, L., Raizada, M.K., Sumners, C. and Katovich, M.J. (2012) Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp. Physiol. 97, 89-101.
159. Yang, Z., Bove, C.M., French, B.A., Epstein, F.H., Berr, S.S., DiMaria, J.M., Gibson, J.J., Carey, RM. and Kramer, C.M. (2002) Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 106, 106-111.
160. Dandapat, A., Hu, C.P., Chen, J., Liu, Y., Khan, J.A., Remeo, F., Carey, R.M., Hermonat, P.L. and Mehta, J.L. (2008) Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem. Biophys. Res. Commun. 366, 871-877.
161. Hu, C., Dandapat, A., Chen, J., Liu, Y., Hermonat, P.L., Carey, R.M. and Mehta, J.L. (2008) Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis 199, 288-294.
162. Oishi, Y., Ozono, R., Yoshizumi, M., Akishita, M., Horiuchi, M. and Oshima, T. (2006) AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci. 80, 82-88.
163. Iwai, M., Chen, R., Li, Z., Shiuchi, T., Suzuki, J., Ide, A., Tsuda, M., Okumura, M., Min, L.J., Mogi, M. and Horiuchi, M. (2005) Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112, 1636-1643.
164. Sales, V.L., Sukhova, G.K., Lopez-Ilasaca, M.A., Libby, P., Dzau, V.J. and Pratt, R.E. (2005) Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 112, 3328-3336.
165. Takata, H., Yamada, H., Kawahito, H., Kishida, S., Irie, D., Kato, T., Wakana, N., Miyagawa, S., Fukui, K. and Matsubara, H. (2015) Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism. J. Renin Angiotensin Aldosterone Syst. 16, 311-320.
166. Kato, T., Kawahito, H., Kishida, S., Irie, D., Wakana, N., Kikai, M., Takata, H., Ogata, T., Ueyama, T., Matoba, S. and Yamada, H. (2014) Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions. J. Renin Angiotensin Aldosterone Syst. 16, 936-946.
167. Senbonmatsu, T., Ichihara, S., Price, Jr, E., Gaffney, F.A. and Inagami, T. (2000) Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest. 106, R25-R29.
168. Ichihara, S., Senbonmatsu, T., Price, Jr, E., Ichiki, T., Gaffney, F.A. and Inagami, T. (2001) Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104, 346-351.
169. Yan, X., Price, R.L., Nakayama, M., Ito, K., Schuldt, A.J., Manning, W.J., Sanbe, A., Borg, T.K., Robbins, J. and Lorell, B.H. (2003) Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 285, H2179-H2187.
170. Nakayama, M., Yan, X., Price, R.L., Borg, T.K., Ito, K., Sanbe, A., Robbins, J. and Lorell, B.H. (2005) Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 288, H317-H327.
171. Yvan-Charvet, L., Even, P., Bloch-Faure, M., Guerre-Millo, M., Moustaid-Moussa, N., Ferre, P. and Quignard-Boulange, A. (2005) Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54, 991-999.
172. D'Amore, A., Black, M.J. and Thomas, W.G. (2005) The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46, 1347-1354.
173. Nasser, M., Clere, N., Botelle, L., Javellaud, J., Oudart, N., Faure, S. and Achard, J.M. (2014) Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice. Cardiovasc. Diabetol. 13, 40.
174. Matsushita, K., Wu, Y., Pratt, R.E. and Dzau, V.J. (2015) Blockade of angiotensin II type 2 receptor by PD123319 inhibits osteogenic differentiation of human mesenchymal stem cells via inhibition of extracellular signal-regulated kinase signaling. J. Am. Soc. Hypertens. 9, 517-525.
175. Daugherty, A., Rateri, D.L., Lu, H., Inagami, T. and Cassis, L.A. (2004) Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110, 3849-3857.
176. Daugherty, A., Rateri, D.L., Howatt, D.A., Charnigo, R. and Cassis, L.A. (2013) PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS One 8, e61849.
177. Xu, J., Sun, Y., Carretero, O.A., Zhu, L., Harding, P., Shesely, E.G., Dai, X., Rhaleb, N.E., Peterson, E. and Yang, X.P. (2014) Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction. Hypertension 63, 1251-1259.
178. Brede, M., Hadamek, K., Meinel, L., Wiesmann, F., Peters, J., Engelhardt, S., Simm, A., Haase, A., Lohse, M.J. and Hein, L. (2001) Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation 104, 2602-2607.
179. Akishita, M., Iwai, M., Wu, L., Zhang, L., Ouchi, Y., Dzau, V.J. and Horiuchi, M. (2000) Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 102, 1684-1689.
180. Wu, L., Iwai, M., Nakagami, H., Li, Z., Chen, R., Suzuki, J., Akishita, M., de Gasparo, M. and Horiuchi, M. (2001) Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104, 2716-2721.
181. Kaschina, E., Grzesiak, A., Li, J., Foryst-Ludwig, A., Timm, M., Rompe, F., Sommerfeld, M., Kemnitz, U.R., Curato, C., Namsolleck, P. et al. (2008) Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118, 2523-2532.
182. Paulis, L., Becker, S.T., Lucht, K., Schwengel, K., Slavic, S., Kaschina, E., Thöne-Reineke, C., Dahlöf, B., Baulmann, J., Unger, T. and Steckelings, U.M. (2012) Direct angiotensin II type 2 receptor stimulation in Nomega-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension 59, 485-492.
183. Bosnyak, S., Welungoda, I.K., Hallberg, A., Alterman, M., Widdop, R.E. and Jones, E.S. (2010) Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 159, 709-716.
184. Rehman, A., Leibowitz, A., Yamamoto, N., Rautureau, Y., Paradis, P. and Schiffrin, E.L. (2012) Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 59, 291-299.
185. Verdonk, K., Durik, M., Abd-Alla, N., Batenburg, W.W., van den Bogaerdt, A.J., van Veghel, R., Roks, A.J., Danser, A.H. and van Esch, J.H. (2012) Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism. Hypertension 60, 722-729.
186. Steckelings, U.M., Fredgart, M., Leurgans, T., Stenelo, M., Nybo, M., Rasmussen, L.M. and De Mey, J.G. (2015) Abstract P143: The angiotensin AT2 receptor agonist compound 21 is a low affinity thromboxane A2 receptor antagonist. Hypertension 66(Suppl 1), AP143
187. Brouwers, S., Smolders, I., Massie, A. and Dupont, A.G. (2013) Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo. Hypertension 62, 920-926.
188. Hilliard, L.M., Chow, C.L., Mirabito, K.M., Steckelings, U.M., Unger, T., Widdop, R.E. and Denton, K.M. (2014) Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats. Hypertension 64, 378-383.
189. Gelosa, P., Pignieri, A., Fandriks, L., de Gasparo, M., Hallberg, A., Banfi, C., Castiglioni, L., Turolo, L., Guerrini, U., Tremoli, E. and Sironi, L. (2009) Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J. Hypertens. 27, 2444-2451.
190. Gao, J., Zhang, H., Le, K.D., Chao, J. and Gao, L. (2011) Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am. J. Hypertens. 24, 724-730.
191. Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Knoell, D.L., Feldman, D.S. and Elton, T.S. (2007) TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L790-L799.
192. Rosenkranz, S. (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 63, 423-432.
193. Sampson, A.K., Irvine, J.C., Shihata, W.A., Dragoljevic, D., Lumsden, N., Huet, O., Barnes, T., Unger, T., Steckelings, U.M. and Jennings, G.L. (2016) Compound 21, a selective agonist of angiotensin AT receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br. J. Pharmacol. 173, 729-740.
194. Kang, D.H., Yu, E.S., Yoon, K.I. and Johnson, R. (2004) The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am. J. Pathol. 164, 679-688.
195. Silbiger, S.R. and Neugarten, J. (2003) The role of gender in the progression of renal disease. Adv. Ren. Replace. Ther. 10, 3-14.
196. Miller, J.A., Anacta, L.A. and Cattran, D.C. (1999) Impact of gender on the renal response to angiotensin II. Kidney Int. 55, 278-285.
197. Naito, Y., Tsujino, T., Fujioka, Y., Ohyanagi, M. and Iwasaki, T. (2002) Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension 40, 827-833.
198. Kang, A.K., Duncan, J.A., Cattran, D.C., Floras, J.S., Lai, V., Scholey, J.W. and Miller, J.A. (2001) Effect of oral contraceptives on the renin angiotensin system and renal function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R807-R813.
199. Ahmed, S.B., Kang, A.K., Burns, K.D., Kennedy, C.R., Lai, V., Cattran, D.C., Scholey, J.W. and Miller, J.A. (2004) Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J. Am. Soc. Nephrol. 15, 780-786.
200. Liu, H.W., Iwai, M., Takeda-Matsubara, Y., Wu, L., Li, J.M., Okumura, M., Cui, T.X. and Horiuchi, M. (2002) Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 40, 451-457.
201. Tsuda, M., Iwai, M., Li, J.M., Li, H.S., Min, L.J., Ide, A., Okumura, M., Suzuki, J., Mogi, M., Suzuki, H. and Horiuchi, M. (2005) Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 45, 545-551.
202. Miller, J.A., Cherney, D.Z., Duncan, J.A., Lai, V., Burns, K.D., Kennedy, C.R., Zimpelmann, J., Gao, W., Cattran, D.C. and Scholey, J.W. (2006) Gender differences in the renal response to renin-angiotensin system blockade. J. Am. Soc. Nephrol. 17, 2554-2560.
203. Wu, H., Roks, A.J., Leijten, F.P., Garrelds, I.M., Musterd-Bhaggoe, U.M., van den Bogaerdt, A.J., de Maat, M.P., Simoons, M.L., Danser, A.H. and Oeseburg, H. (2014) Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease. Clin. Sci. (Lond). 126, 441-449.
204. Cherney, D.Z., Sochett, E.B. and Miller, J.A. (2005) Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int. 68, 1722-1728.
205. Ruggenenti, P., Perna, A., Zoccali, C., Gherardi, G., Benini, R., Testa, A. and Remuzzi, G. (2000) Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J. Am. Soc. Nephrol. 11, 88-96.
206. Armando, I., Jezova, M., Juorio, A.V., Terron, J.A., Falcon-Neri, A., Semino-Mora, C., Imboden, H. and Saavedra, J.M. (2002) Estrogen upregulates renal angiotensin II AT(2) receptors. Am. J. Physiol. Renal Physiol. 283, F934-F943.
207. Baiardi, G., Macova, M., Armando, I., Ando, H., Tyurmin, D. and Saavedra, J.M. (2005) Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul. Pept. 124(1-3), 7-17.
208. Hilliard, L.M., Jones, E.S., Steckelings, U.M., Unger, T., Widdop, R.E. and Denton, K.M. (2012) Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension 59, 409-414.
209. Okumura, M., Iwai, M., Ide, A., Mogi, M., Ito, M. and Horiuchi, M. (2005) Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression. Hypertension 46, 577-583.
210. Okumura, M., Iwai, M., Nakaoka, H., Sone, H., Kanno, H., Senba, I., Ito, M. and Horiuchi, M. (2011) Possible involvement of AT2 receptor dysfunction in age-related gender difference in vascular remodeling. J. Am. Soc. Hypertens. 5, 76-84.
211. Hilliard, L.M., Mirabito, K.M. and Denton, K.M. (2013) Unmasking the potential of the angiotensin AT2 receptor as a therapeutic target in hypertension in men and women: what we know and what we still need to find out. Clin. Exp. Pharmacol. Physiol. 40, 542-550.
212. Yanes, L.L., Romero, D.G., Iliescu, R., Zhang, H., Davis, D. and Reckelhoff, J.F. (2010) Postmenopausal hypertension: role of the renin-angiotensin system. Hypertension 56, 359-363.
213. Sampson, A.K., Moritz, K.M., Jones, E.S., Flower, R.L., Widdop, R.E. and Denton, K.M. (2008) Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 52, 666-671.
214. Sampson, A.K., Hilliard, L.M., Moritz, K.M., Thomas, M.C., Tikellis, C., Widdop, R.E. and Denton, K.M. (2012) The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R159-R165.
215. Brown, R.D., Hilliard, L.M., Head, G.A., Jones, E.S., Widdop, R.E. and Denton, K.M. (2012) Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension 59, 129-135.
216. McCarthy, C.A., Widdop, R.E., Denton, K.M. and Jones, E.S. (2013) Update on the angiotensin AT(2) receptor. Curr. Hypertens. Rep. 15, 25-30.
217. Hilliard, L.M., Nematbakhsh, M., Kett, M.M., Teichman, E., Sampson, A.K., Widdop, R.E., Evans, R.G. and Denton, K.M. (2011) Gender differences in pressure-natriuresis and renal autoregulation: role of the angiotensin type 2 receptor. Hypertension 57, 275-282.
218. Viegas, V.U., Liu, Z.Z., Nikitina, T., Perlewitz, A., Zavaritskaya, O., Schlichting, J., Persson, P.B., Regitz-Zagrosek, V., Patzak, A. and Sendeski, M.M. (2012) Angiotensin II type 2 receptor mediates sex differences in mice renal interlobar arteries response to angiotensin II. J Hypertens 30, 1791-1798.
219. Pettersson-Fernholm, K., Frojdo, S., Fagerudd, J., Thomas, M.C., Forsblom, C., Wessman, M., Groop, P.H., FinnDiane Study Group. (2006) The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patients. Kidney Int. 69, 1880-1884.
220. Steckelings, U.M., Paulis, L., Namsolleck, P. and Unger, T. (2012) AT2 receptor agonists: hypertension and beyond. Curr Opin. Nephrol. Hypertens. 21, 142-146.
221. Sumners, C., de Kloet, A.D., Krause, E.G., Unger, T. and Steckelings, U.M. (2015) Angiotensin type 2 receptors: blood pressure regulation and end organ damage. Curr. Opin. Pharmacol. 21, 115-121.
222. Jalowy, A., Schulz, R., Dorge, H., Behrends, M. and Heusch, G. (1998) Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J. Am. Coll. Cardiol. 32, 1787-1796.
223. Jones, E.S., Black, M.J. and Widdop, R.E. (2004) Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. J. Mol. Cell. Cardiol. 37, 1023-1030.
224. Desai, A. (2008) Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation 118, 1609-1611.
225. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, Jr, J.L., Jones, D.W., Materson, B.J., Oparil, S., Wright, Jr, J.T. et al. (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206-1252.
226. Chen, Y.W., Tran, S., Chenier, I., Chan, J.S., Ingelfinger, J.R., Inagami, T. and Zhang, S.L. (2008) Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis. Pediatr. Nephrol. 23, 1769-1777.
227. Nishimura, H., Yerkes, E., Hohenfellner, K., Miyazaki, Y., Ma, J., Hunley, T.E., Yoshida, H., Ichiki, T., Threadgill, D., Phillips, 3rd, J.A. et al. (1999) Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol. Cell 3, 1-10.
228. Obst, M., Gross, V., Janke, J., Wellner, M., Schneider, W. and Luft, F.C. (2003) Pressure natriuresis in AT(2) receptor-deficient mice with L-NAME hypertension. J. Am. Soc. Nephrol. 14, 303-310.
229. Siragy, H.M., Senbonmatsu, T., Ichiki, T., Inagami, T. and Carey, R.M. (1999) Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J. Clin. Invest. 104, 181-188.
230. Shao, C., Yu, L. and Gao, L. (2014) Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection. Endocrinology 155, 793-804.
231. Matavelli, L.C., Huang, J. and Siragy, H.M. (2011) Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57, 308-313.
232. Dhande, I., Ali, Q. and Hussain, T. (2013) Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension 61, 1218-1226.
233. Ali, Q., Patel, S. and Hussain, T. (2015) Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats. Am. J. Physiol. Renal Physiol. 308, F1379-F1385.
234. Hrenak, J., Arendasova, K., Rajkovicova, R., Aziriova, S., Repova, K., Krajcirovicova, K., Celec, P., Kamodyová, N., Bárta, A., Adamcová, M. et al. (2013) Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats. Physiol. Res.62 Suppl 1, S181-S189.
235. Gao, J., Zucker, I.H. and Gao, L. (2014) Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Am. J. Hypertens. 27, 1248-1256.
236. Bruce, E., Shenoy, V., Rathinasabapathy, A., Espejo, A., Horowitz, A., Oswalt, A., Francis, J., Nair, A., Unger, T., Raizada, M.K. et al. (2015) Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br. J. Pharmacol. 172, 2219-2231.
237. Kukida, M., Mogi, M., Ohshima, K., Nakaoka, H., Iwanami, J., Kanno, H., Tsukuda, K., Chisaka, T., Min, L.J., Wang, X.L. et al. (2016) Angiotensin II type 2 receptor inhibits vascular intimal proliferation with activation of PPARgamma. Am. J. Hypertens. 29, 727-736.